Additionally, the researchers found that while making up only 4% of total estrogen-related receptors, the gamma receptor was able to compensate for alpha receptor loss under normal conditions.

It blocks the alpha 1 receptor of IL-13 but not the alpha 2 receptor. It's thought that this property gives it a regulatory effect favorable to its efficacy.